Although in the vast majority of these cases, we do not know how the human-specific changes impact oncogenesis, a positive association with survival in glioblastoma was found for the intact SIGLEC16-positive (activating Siglec) cases (9). This evidence concerns the gene SIGLEC16 and glioblastoma.